The cinnamon administrations significantly reduced FM at the dosages of ≥2 g/d , when administered for ≥12 weeks .
Cinnamon administration result ed in BW and WC reduction in non-linear fashion ( P = 0.04 ) .
Cinnamon supplementation significantly affects obesity measures .
BACKGROUND & AIMS Data about the effects of cinnamon supplementation on obesity measures are conflicting .
This systematic review and meta- analysis of r and omized controlled trials ( RCTs ) was conducted to summarize the effects of cinnamon intake on body weight ( BW ) , Body Mass Index ( BMI ) , Waist Circumference ( WC ) , and fat mass ( FM ) in adults .
Efficacy of cinnamon in patients with type II diabetes mellitus: A randomized controlled clinical trial.
BACKGROUND & AIMS Multiple studies have evaluated the hypoglycemic effect of cinnamon in patients with diabetes mellitus ( DM ) type II , with conflicting results . Differences in Baseline Body Mass Index ( BMI ) of patients may be able to explain the observed differences in the results . This study was design ed to evaluate the effect of cinnamon supplementation on anthropometric , glycemic and lipid outcomes of patients with DM type II based on their baseline BMI . METHODS The study was design ed as a triple-blind placebo-controlled r and omized clinical trial , using a parallel design . One hundred and forty patients referred to Diabetes Clinic of Yazd University of Medical Sciences with diagnosis of DM type II were r and omly assigned in four groups : cinnamon ( BMI ≥ 27 , BMI < 27 ) and Placebo ( BMI ≥ 27 , BMI < 27 ) . Patients received cinnamon bark powder or placebo in 500 mg capsules twice daily for 3 months . Anthropometric , glycemic and lipid outcomes were measured before and after the intervention . RESULT Cinnamon supplementation led to improvement of all anthropometric ( BMI , body fat , and visceral fat ) , glycemic ( FPG , 2hpp , HbA1C , Fasting Insulin , and Insulin Resistance ) , and lipids ( Cholesterol Total , LDL-c and HDL-c ) outcomes ( except for triglycerides level ) . All observed changes ( except for Cholesterol Total and LDL-c ) were significantly more prominent in patients with higher baseline BMI ( BMI ≥ 27 ) . CONCLUSION Based on the study findings , cinnamon may improve anthropometric parameters , glycemic indices and lipid profile of patients with type II diabetes . These benefits are significantly more prominent in patients with higher baseline BMI ( BMI ≥ 27 ) . The trial protocol was registered in Iranian Registry of Clinical Trials data base ( registration ID : I RCT 2017031133015N1 )
The cinnamon administrations significantly reduced FM at the dosages of ≥2 g/d , when administered for ≥12 weeks .
Cinnamon administration result ed in BW and WC reduction in non-linear fashion ( P = 0.04 ) .
Cinnamon supplementation significantly affects obesity measures .
BACKGROUND & AIMS Data about the effects of cinnamon supplementation on obesity measures are conflicting .
This systematic review and meta- analysis of r and omized controlled trials ( RCTs ) was conducted to summarize the effects of cinnamon intake on body weight ( BW ) , Body Mass Index ( BMI ) , Waist Circumference ( WC ) , and fat mass ( FM ) in adults .